Lenvima 4 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FU242
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,321
Award facts
- Contract value 100% obligated
- $32,321.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of LENVIMA 4 MG capsules (30-count units) with a ceiling value of $32,321.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of December 19, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant position as a critical federal medical procurement vendor, particularly for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its capability to fulfill federal pharmaceutical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. LENVIMA (lenvatinib) is a targeted cancer therapy medication, reflecting the company's role in supplying specialized oncology treatments through the federal supply chain to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FU242?
SPE2DR26FU242 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FU242 worth?
The government has obligated $32,321 on SPE2DR26FU242.
Is contract SPE2DR26FU242 an order under another contract?
Yes. SPE2DR26FU242 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU242 competed?
The extent of competition for SPE2DR26FU242 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award